share_log

Stephens & Co. Maintains Equal-Weight on Anika Therapeutics, Lowers Price Target to $23

Benzinga ·  Aug 10, 2023 10:16

Stephens & Co. analyst George Sellers maintains Anika Therapeutics (NASDAQ:ANIK) with a Equal-Weight and lowers the price target from $28 to $23.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment